Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

Lung cancer screening with low-dose CT could have saved tens of thousands of lives—if only we'd listened to the data back in ...

ADRs came under pressure in the premarket on Thursday after the company announced its decision to halt a clinical program ...

Lung cancer screening has the potential to catch lung cancer early and save lives—but only if people get screened. Although ...

Only half of study participants continued to get annual lung cancer screenings at least two years after their first.

BeiGene is ending development of its experimental lung-cancer treatment ociperlimab following the failure of a late-stage study. BeiGene on Thursday said it is stopping a Phase 3 trial of ociperlimab ...

Amit Gupta, MD, discussed a new collaboration between University Hospitals Cleveland Medical Center and Qure.ai that aims to ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had ...

TIGIT in particular has proved to be a tricky target for drug developers, and BeiGene's decision comes just a few months after MSD abandoned the development of its anti-TIGIT antibody vibostolimab ...

Patient and caregiver engagement interventions show significant potential for improving lung cancer outcomes, according to a systematic review in Lung Cancer.

Feb. 12, 2025 — Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous ... Feb. 6, 2025 ...

Lung cancer is the most common cancer for men and women in Hawaii and in recent years, the state has ranked last in the ...